Are Anti-centromere Antibodies (aCENP) Predictive of Systemic Sclerosis Development in Patients Without Raynaud's Phenomenon?

被引:0
|
作者
Alvear-Torres, Andrea [1 ,2 ,3 ]
Martinez-Becerra, Maria Jose [3 ]
Vegas-Sanchez, Maria Carmen [3 ,4 ,5 ]
Recuero-Diaz, Sheila [1 ,2 ,3 ]
Perez-ferro, Maria [6 ]
Sanchez-Pernaute, Olga [1 ,2 ,7 ]
机构
[1] Hosp Univ Fdn Jimenez Diaz, Dept Rheumatol, Madrid, Spain
[2] Hosp Univ Fdn Jimenez Diaz, Joint & Bone Res Unit, Madrid, Spain
[3] IIS FJD, Madrid, Spain
[4] Hosp Univ Fdn Jimenez Diaz, Dept Immunol, Madrid, Spain
[5] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain
[6] Hosp Univ Rey Juan Carlos, Dept Rheumatol, Madrid, Spain
[7] Autonomous Univ Madrid, IIS FJD, Madrid, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2472
引用
收藏
页码:5026 / 5027
页数:2
相关论文
共 50 条
  • [21] RAYNAUD'S PHENOMENON AND SYSTEMIC SCLEROSIS
    Denton, C. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 15 - 16
  • [22] Atypical anticentromere autoantibodies from patients without Raynaud's phenomenon or systemic sclerosis recognize minor epitopes on centromere proteins.
    VazquezAbad, D
    Senecal, JL
    Rothfield, N
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 321 - 321
  • [23] Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?
    Benyamine, Audrey
    Bertin, Daniel
    Heim, Xavier
    Granel, Brigitte
    Bardin, Nathalie
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 44 : E42 - E44
  • [24] ANTI-CENTROMERE ANTIBODIES AFFECT EMBRYONIC DEVELOPMENT.
    Kumagawa, Yoshie
    Ihara, Kazuho
    Tokoro, Mikiko
    Fukunaga, Noritaka
    Asada, Yoshimasa
    FERTILITY AND STERILITY, 2024, 122 (04) : E231 - E231
  • [25] The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary Raynaud’s phenomenon
    Slavica R. Pavlov-Dolijanovic
    Nemanja S. Damjanov
    Nada Z. Vujasinovic Stupar
    Snezana Baltic
    Dragan D. Babic
    Rheumatology International, 2013, 33 : 2967 - 2973
  • [26] The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary Raynaud's phenomenon
    Pavlov-Dolijanovic, Slavica R.
    Damjanov, Nemanja S.
    Vujasinovic Stupar, Nada
    Baltic, Snezana
    Babic, Dragan D.
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (12) : 2967 - 2973
  • [27] Ability of anti-centromere and anti-topoisomerase antibodies to distinguish subsets of skin involvement in systemic sclerosis.
    Hudson, Marie
    Taillefer, Suzanne
    Steele, Russell
    Fritzler, Marvin
    Baron, Murray
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S482 - S482
  • [28] Audiovestibular Manifestations in Patients with Primary Raynaud's Phenomenon and Raynaud's Phenomenon Secondary to Systemic Sclerosis
    Carlos Amor-Dorado, Juan
    Martin-Sanz, Eduardo
    Franco-Gutierrez, Virginia
    Urruticoechea-Arana, Ana
    Garcia-Arumi, Ana M.
    Racines-Alava, Erwin
    Aleman-Lopez, Oscar
    Simeon-Aznar, Carmen P.
    Gonzalez-Gay, Miguel A.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [29] The predictive value of scleroderma pattern capillary changes and antinuclear antibodies for the development of systemic sclerosis in 1371 patient with raynaud's phenomenon
    Damjanov, N. S.
    Dolijanovic, S. R. Pavlov
    Gavrilov, N.
    Marcetic, D.
    Vlahovic, N.
    Djurovic, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 205 - 206
  • [30] MYOCARDIAL INVOLVEMENT CHARACTERIZES EARLY SYSTEMIC SCLEROSIS WITH ANTI-SCL70 ANTIBODIES AND LONGSTANDING DISEASE WITH ANTI-CENTROMERE ANTIBODIES
    De Santis, M.
    Tonutti, A.
    Motta, F.
    Rodolfi, S.
    Monti, L.
    Francone, M.
    Selmi, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 988 - 989